The clearance effect of bovine anti-Helicobacter pylori antibody-containing milk in O blood group Helicobacter pylori-infected patients: a randomized double-blind clinical trial

[1]  J. Kim,et al.  Sequential or concomitant therapy for eradication of Helicobacter pylori infection: A systematic review and meta‐analysis , 2015, Journal of gastroenterology and hepatology.

[2]  M. Zolfaghari,et al.  The frequency of Helicobacter pylori in dental plaque is possibly underestimated. , 2015, Archives of oral biology.

[3]  N. Lu,et al.  Review: Clinical Management of Helicobacter pylori Infection in China , 2015, Helicobacter.

[4]  S. Cao,et al.  Preparation of specific anti-Helicobacter pylori yolk antibodies and their antibacterial effects. , 2014, International journal of clinical and experimental pathology.

[5]  F. Khamesipour,et al.  Helicobacter pylori in Vegetables and Salads: Genotyping and Antimicrobial Resistance Properties , 2014, BioMed research international.

[6]  Isabella Leone,et al.  High Exposure, Spontaneous Clearance, and Low Incidence of Active Helicobacter pylori Infection: The Sorbo San Basile Study , 2014, Helicobacter.

[7]  A. Talebi Bezmin abadi.  Therapy of Helicobacter pylori: Present Medley and Future Prospective , 2014, BioMed research international.

[8]  M. Oleastro,et al.  The Role of Helicobacter pylori Outer Membrane Proteins in Adherence and Pathogenesis , 2013, Biology.

[9]  C. Scarpignato,et al.  Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy , 2013, BMJ.

[10]  M. Riccioni,et al.  Update on triple therapy for eradication of Helicobacter pylori : current status of the art , 2012 .

[11]  T. Cover,et al.  J-Western Forms of Helicobacter pylori cagA Constitute a Distinct Phylogenetic Group with a Widespread Geographic Distribution , 2012, Journal of bacteriology.

[12]  E. Kuipers,et al.  Bovine antibody-based oral immunotherapy for reduction of intragastric Helicobacter pylori colonization: a randomized clinical trial. , 2011, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[13]  C. Reis,et al.  Helicobacter pylori adhesion to gastric epithelial cells is mediated by glycan receptors. , 2010, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[14]  D. Sgouras,et al.  CagA and VacA Polymorphisms Are Associated with Distinct Pathological Features in Helicobacterpylori-Infected Adults with Peptic Ulcer and Non-Peptic Ulcer Disease , 2010, Journal of Clinical Microbiology.

[15]  R. Robins-Browne,et al.  Antibody-Mediated Protection against Infection with Helicobacter pylori in a Suckling Mouse Model of Passive Immunity , 2009, Infection and Immunity.

[16]  A. Abbas,et al.  Efficacy of Passive Immunization with IgY Antibodies to a 58-kDa H. pylori Antigen on Severe Gastritis in BALB/c Mouse Model , 2009, Journal of immunoassay & immunochemistry.

[17]  M. Rezadehbashi,et al.  Distribution of Helicobacter pylori cagA, cagE, oipA and vacA in different major ethnic groups in Tehran, Iran , 2009, Journal of gastroenterology and hepatology.

[18]  C. Nilsson,et al.  Lipopolysaccharide Diversity Evolving in Helicobacter pylori Communities through Genetic Modifications in Fucosyltransferases , 2008, PloS one.

[19]  G. Perez-Perez,et al.  Diversity of VacA Intermediate Region among Helicobacter pylori Strains from Several Regions of the World , 2008, Journal of Clinical Microbiology.

[20]  S. Schuster,et al.  Genomic diversity in Helicobacter and related organisms. , 2007, Research in microbiology.

[21]  E. Papp-Szabó,et al.  A novel Helicobacter pylori cell-surface polysaccharide. , 2005, Carbohydrate Research.

[22]  M. Blaser,et al.  High Frequency of Gastric Colonization with Multiple Helicobacter pylori Strains in Venezuelan Subjects , 2005, Journal of Clinical Microbiology.

[23]  E. Kuijper,et al.  Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical data. , 2005, Journal of medical microbiology.

[24]  M. Blaser,et al.  Functional Adaptation of BabA, the H. pylori ABO Blood Group Antigen Binding Adhesin , 2004, Science.

[25]  T. Hibi,et al.  Effect of dietary anti‐Helicobacter pylori‐urease immunoglobulin Y on Helicobacter pylori infection , 2004, Alimentary pharmacology & therapeutics.

[26]  M. Cześnikiewicz-Guzik,et al.  Association of the presence of Helicobacter pylori in the oral cavity and in the stomach. , 2004, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[27]  Y. Yamaoka,et al.  Analysis of Helicobacter pylori Genotypes and Correlation with Clinical Outcome in Turkey , 2004, Journal of Clinical Microbiology.

[28]  M. Hänninen,et al.  Prevention and Suppression of Helicobacter felis Infection in Mice Using Colostral Preparation with Specific Antibodies , 2003, Helicobacter.

[29]  L. Björck,et al.  Bovine Anti- Helicobacter pylori Antibodies for Oral Immunotherapy , 2002, Scandinavian journal of gastroenterology.

[30]  M. Kane,et al.  Bactericidal effect of a whey protein concentrate with anti‐Helicobacter pylori activity , 2001, Journal of applied microbiology.

[31]  M. Blaser,et al.  Allelic Variation within Helicobacter pylori babA and babB , 2001, Infection and Immunity.

[32]  L. Hammarström,et al.  Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients , 1999, Bone Marrow Transplantation.

[33]  Terry,et al.  Novel therapies for Helicobacter pylori infection , 1999, Alimentary pharmacology & therapeutics.

[34]  M. Blaser,et al.  Expanding Allelic Diversity of Helicobacter pylori vacA , 1998, Journal of Clinical Microbiology.

[35]  Fuchs,et al.  Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum , 1998, Alimentary Pharmacology and Therapeutics.

[36]  M. Blaser,et al.  Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between h. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. , 1998, The Journal of biological chemistry.

[37]  D. Philpott,et al.  Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrum. , 1998, The Journal of infectious diseases.

[38]  Mark Borodovsky,et al.  The complete genome sequence of the gastric pathogen Helicobacter pylori , 1997, Nature.

[39]  M. Blaser,et al.  Expression of the human cell surface glycoconjugates Lewis x and Lewis y by Helicobacter pylori isolates is related to cagA status , 1996, Infection and immunity.

[40]  R. Negrini,et al.  Typing of Helicobacter pylori with monoclonal antibodies against Lewis antigens in lipopolysaccharide , 1996, Journal of clinical microbiology.

[41]  H. Vainio,et al.  Working group report on schistosomes, liver flukes and Helicobacter pylori. Meeting held at IARC, LYON, 7–14 june 1994 , 1995, International journal of cancer.

[42]  O. Torres,et al.  Protection against Campylobacter diarrhea: role of milk IgA antibodies against bacterial surface antigens , 1993, Acta paediatrica.

[43]  W. Coward,et al.  Protection by human milk IgA against Helicobacter pylori infection in infancy , 1993, The Lancet.

[44]  G. Ruiz-Palacios,et al.  Protection of breast-fed infants against Campylobacter diarrhea by antibodies in human milk. , 1990, The Journal of pediatrics.

[45]  G. Davidson,et al.  PASSIVE IMMUNISATION OF CHILDREN WITH BOVINE COLOSTRUM CONTAINING ANTIBODIES TO HUMAN ROTAVIRUS , 1989, The Lancet.

[46]  B. Marshall,et al.  UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION , 1984, The Lancet.

[47]  Y. Beyth,et al.  ALPHA-FETOPROTEIN DURING MID-TRIMESTER INDUCED ABORTION , 1975, The Lancet.

[48]  C. Hassan,et al.  Standard triple and sequential therapies for Helicobacter pylori eradication: an update. , 2013, European journal of internal medicine.

[49]  M. Mercado-Reyes,et al.  Prevalence of cagA, vacA, babA2 and iceA genes in H. pylori strains isolated from Colombian patients with functional dyspepsia. , 2012, Polish journal of microbiology.

[50]  J. Solnick,et al.  Modulation of attachment proteins in Helicobacter pylori , 2011 .

[51]  Y. Yamaoka,et al.  Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. , 2008, Internal medicine.

[52]  G. Faller,et al.  Role of the alpAB proteins and lipopolysaccharide in adhesion of Helicobacter pylori to human gastric tissue. , 2002, International journal of medical microbiology : IJMM.

[53]  S. Czinn,et al.  Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. , 1993, Vaccine.